http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1529403-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cac023d2e2874224ecbbcccbdea1fc91
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
filingDate 1976-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1978-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1529403-A
titleOfInvention Isoxazole derivative
abstract 1529403 Isoxazole derivatives KYORIN PHARMACEUTICAL CO Ltd 9 June 1976 [21 June 1975] 23841/76 Heading C2C Novel anti-diabetic compounds of the formula where R is a carboxy, ethoxycarbonyl or carbamoyl group are made by reacting 3- methylisoxazole-5-carbonyl chloride with a compound of formula
priorityDate 1975-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12905099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422118978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416224855

Total number of triples: 20.